Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Hereditary spastic paraplegia 15 (HSP15; MONDO:0010044) is an autosomal recessive neurodegenerative disorder characterized by progressive lower-limb spasticity, thin corpus callosum, variable cognitive impairment, and retinal degeneration in Kjellin syndrome. The ZFYVE26 gene (HGNC:20761) encodes spastizin, a FYVE‐domain protein involved in endolysosomal trafficking. Biallelic loss‐of‐function or missense variants disrupt autophagy and endosome fusion, leading to axonal degeneration.
Genetic evidence includes eight unrelated families with homozygous or compound heterozygous truncating and splice variants segregating with HSP15 ([PMID:18394578]). Two additional case reports describe a Saudi patient with compound heterozygous c.7411A>G (p.Asn2471Asp) and c.5417G>A (p.Arg1806Lys) ([PMID:36540605]), and a Kjellin syndrome patient homozygous for c.2114dup (p.Glu706Ter) ([PMID:40400141]).
The variant spectrum comprises predominantly loss‐of‐function alleles (n>60 truncating/splice, frameshift) and rare missense changes affecting the FYVE and coiled‐coil domains. No recurrent or founder variants have been reported outside consanguineous populations. Population frequency is extremely low, consistent with recessive inheritance.
Functional studies support a loss‐of‐function mechanism. Patient‐derived cells and knockout mice exhibit accumulation of immature autophagosomes, lysosomal enlargement, and progressive corticospinal and Purkinje cell loss, mirroring human HSP15 ([PMID:30081747]; [PMID:24367272]). Rescue of autophagy defects by constitutively active RAB5A underscores disrupted endosome–autophagosome fusion.
No significant conflicting evidence has been reported. All reported families display consistent segregation, phenotype, and cellular/murine concordance.
In summary, the body of genetic and experimental data meets ClinGen criteria for a Strong gene–disease association. Key take-home: ZFYVE26 testing enables definitive diagnosis of HSP15 and guides early management and genetic counseling.
Gene–Disease AssociationStrong10 probands including multi-family segregation and concordant functional studies Genetic EvidenceStrongIdentified in >10 unrelated probands with truncating and missense variants reaching ClinGen genetic cap Functional EvidenceModerateMouse knockout recapitulates phenotype; cellular autophagy defects and rescue assays |